The Cost of Cancer Treatment Study's Design and Methods
Traditionally, the cost of conducting cancer clinical trials has been supported by a combination of research sponsors, institutions, and third-party payers. However, health insurers and other payers are increasingly reluctant to reimburse for direct patient care provided as part of a clinical trial. These policies — driven in part by a perception that patients enrolled in trials incur substantial additional costs — might impede efforts to enroll patients in clinical trials. Yet there is little evidence regarding the costs of treating patients in clinical trials. Given the great importance of timely clinical research, there is thus an urgent need for unbiased information on the possible effects of participation in government-sponsored clinical trials on patient care costs. Such data would make any cost-sharing burden explicit and could lead to better mechanisms for financing clinical trials. This report documents the design and methods of the Cost of Cancer Treatment Study (CCTS), an ongoing effort to obtain precise and generalizable estimates of the direct care costs of patients who participate in National Cancer Institute-sponsored clinical cancer trials (see www.costofcancer.org). Using a retrospective design, the CCTS will sample multiple clinical trials and cancer providers around the country. Costs of treating patients in clinical trials at these providers will then be compared with a set of matched controls not in any trial, thereby yielding an estimate of the additional cost — if any — associated with clinical trial participation. Because of the large sample size and the recruitment of patients in both academic and community settings, the CCTS will provide precise and generalizable estimates of these costs.
Download eBook for Free
| Format | File Size | Notes |
|---|---|---|
| PDF file | 1.7 MB | Use Adobe Acrobat Reader version 7.0 or higher for the best experience. |
-
Download Individual Chapters Below
Note: Many electronic documents posted prior to 2003 are available as chapter PDFs or HTML files linked from the Contents.
Purchase Print Copy
| Format | List Price | Price | |
|---|---|---|---|
| Paperback, 52 Pages | $8.00 | $6.40 Special 20% Web Discount |  |
Document Details
- Copyright: RAND Corporation
- Availability: Available
- Print Format: Paperback
- Paperback Pages: 52
- List Price: $8.00
- Paperback Price: $6.40
- Paperback ISBN/EAN: 0-8330-2848-0
- Document Number: MR-1169-NCI/NIH/OSTP
- Year: 2000
- Series: Monograph Reports
Contents
Preface PDF
Figures
Figure and Tables PDF
Summary PDF
Acknowledgements
Acknowledgments PDF
Chapter One
Introduction PDF
Chapter Two
Background PDF
Chapter Three
Overview of the Cost of Cancer Treatment Study PDF
Chapter Four
Conclusion PDF
Appendix A
Power Calculations PDF
Appendix B
Instructions for Selecting and Contacting Patients at Member Institutions PDF
Appendix C
Patient Screener/Nonresponse Form PDF
References PDF
The study was conducted within RAND Health.
This report is part of the RAND Corporation monograph report series. The monograph/report was a product of the RAND Corporation from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.
Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.
RAND® is a registered trademark. Copyright © 1994-2013 RAND Corporation.